We are building a transformative force  
in clinical development.

We are listening to what companies want from their drug development partners. We are listening to understand where the clinical research industry has room to improve. And we are listening to what customers want to achieve for their patients. A breakthrough environment with the agility to promote and respond to changes in clinical development and delivery continues to be an imperative. We are taking action. We are forming Fortrea and along with it a new blueprint for excellence in customer service to equal our renowned scientific expertise.

As a provider of phase I-IV clinical trial management, regulatory guidance, patient access solutions and market access consulting, Fortrea will partner with both emerging and large pharmaceutical, biotechnology, device and diagnostic companies to drive healthcare innovation and improve the lives of patients worldwide.

Harnessing our passion for scientific rigor and decades of clinical trial experience, we’re looking to navigate obstacles with agility and ease. We are problem solvers and creative thinkers committed to opening the doors between promising ideas and proven therapies.

Our countdown begins

As a future spin-off from Labcorp, we will be a new company with decades of history.

We are working now to build our team and prepare for our expected mid-2023 formal separation from Labcorp.

“The announcement of Fortrea signals to the world what we are building: a leading, pure-play clinical research organization (CRO) positioned to serve customers, deliver life-changing medicines faster, and create lasting value for all our stakeholders.”

Tom Pike, future CEO and chairman of the board of Fortrea

Our Leadership Team

When the spin-off is complete, the following industry leaders will be filling these Fortrea roles.

CEO and chairman of the Board

Tom Pike

Tom Pike has more than 30 years of industry experience. Currently, he is the president and CEO of the Drug Development clinical development business at Labcorp.

View Tom’s LinkedIn Profile

Chief Medical Officer

Oren Cohen, M.D.

Oren Cohen, M.D., has more than 30 years of experience in leading global scientific and medical research teams. Currently, he is the chief medical officer and president of clinical pharmacology services at Labcorp.

View Oren’s LinkedIn Profile 

Chief Operating Officer

Mark Morais

Mark Morais has more than 20 years of experience with global operations and strategic management. Currently, he is the president of clinical operations and commercial solutions at Labcorp.

View Mark’s LinkedIn Profile